MEEDER ASSET MANAGEMENT INC - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 64 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.5%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$4,000
-20.0%
2,8370.0%0.00%
Q3 2019$5,0002,8370.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 41,909,219$21,793,00011.58%
Kore Private Wealth LLC 202,366$105,0000.02%
BARD ASSOCIATES INC 335,750$175,0000.02%
HighTower Advisors, LLC 5,284,688$2,738,0000.01%
GSA CAPITAL PARTNERS LLP 126,529$66,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 654,200$339,0000.01%
Virtu Financial LLC 57,076$30,0000.01%
WEDBUSH SECURITIES INC 81,500$42,0000.00%
NEXPOINT ASSET MANAGEMENT, L.P. 33,933$18,0000.00%
MATRIX ASSET ADVISORS INC/NY 39,500$20,0000.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders